Publication | Closed Access

Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: A prospective non-randomized controlled trial

Ascorbic Acid Peg-2lChemoprevention StrategyGastrointestinal OncologyMedicinePharmacologyGastroenterologyColorectal CancerEarly Morning ColonoscopiesOncologyRadiation OncologyCancer Research